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THE EFFECTS OF Na-ASCORBATE ON ASCORBATE CONCENTRATION 
IN THE PLASMA AND TISSUES 
Voja Pavlovic * and Zoran Pavlovic ** 
Male guinea pigs of a Hartley-derived strein, a mean starting weight of 325 g + 70 g 
(s.d.), immunized with bovine serum albumine, were studied in animals maintained on various 
amount of ascorbic acid for 28 days. Animals were paid-fed on ascorbate-free diet (standard 
"dry" meal (Wagner Guinea Pig Diet). The animals were immunized with bovine serum albu-
muine (BSA, Miles) 0.2 mg being administered in complete Freund's adjuvans on day 0 (0.025 
mg/foot pad and 0.1 mg in the nuchal skin) and again on day 14 in 1% saline into the nuchal skin. 
The animals were separated into five categories of five animals each and put on a daily schedule 
of intraperitoneal injections of 0, 10,25, l00 i 250 mg Na-ascorbate (Bronson). Blood was taken 
by cardiac puncture from each animal on experimental days 0, 14 and 28. At the end of experi-
ment all animals were anesthetized and tissue samples were taken for evaluation of vitamin C 
with Zannoni methods. The immunized guinea pigs receiving no supplementation showed a re-
duction in ascorbic acid concentration of 59% at 14 days to 67% at 28 days. In the meantime, no 
difference between the 10 and 25 mg doses in relative change. Guinea pigs receiving the mega 
doses (100 mg and 250 mg/day) exhibited increased plasma levels, the former showing a greater 
increase than latter. At the end of the experiment the gain in the 100 mg group had dropped to 
12%, but in the 250 mg group it continued to raise. 
Of greater significance than the plasma levels are the ascorbate concentrations meas-
ured in various tissues of selected animals that had been maintained for 28 days on these ascor-
bate regimens. Intraperitoneal administration of Na-ascorbate a rapid increase of ascorbic acid 
plasma concentration. The greatest the ascorbate concentrations was obtained in the case of the 
adrenal (95.3), pituitary (89.1) and spleen (29.7) per 100 g in the respective cases. Under the 
same circumstances the ascorbate concentrations in the brain and in the eye dropped only to 20% 
of the control value. Acta Medica Medianae 2003; 42 (4):23-27. 
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Introduction 
On the basis of in vitro examination of tissue ho-
mogenate extracts Burns is (1) concluded that, man, 
monkey and guinea pig are unable to convert L-
gulonolactone to L-ascorbic acid, and that this is the 
"missing step" in the biosynthesis in the livers of these 
species which makes them dependent on exogenous 
ascorbic acid for their vitamin C requirements. Chat-
terjee et al. (2) concluded that there exists an additional 
"missing step", namely that performed in other species 
by the enzyme glucuronolactonase in converting D-
clucuronolactone to L-gulonolactone. More specifi-
cally Burns (1), Stone (3) and Chatterjee et al. (2) con-
sidered that the " missing step" is due to gene deletion. 
In his seminal paper "Evolution and the Need for 
Ascorbic Acid" Linus Pauling (4) concluded that the 
loss of the ability to synthesize ascorbic acid probably 
occurred in the common ancestor of the primates. A 
rought estimate of the time at which this mutational 
change occurred is twenty-five million years ago (5). 
Weighty experimental and theoretical considera-
tions will be advanced in favour of the thesis that vitamin 
C deficiency in a number of species including humans is 
not due to rotal inability to biosynthesis ascorbate, but 
rather to a very limited biosynthetic ability which 
normally cannot be stopped up to meet the minimum 
metabolic/physiological requirements (6, 7, 8, 9). 
In the present paper we report the effects of 
supplemental doses of Na-ascorbate on blood and ti-
ssue ascorbic levels from immunized, pair-fed guinea 
pigs maintained on an ascorbate free diet but su-
pplemented with 0, 10, 25, 100 or 250 mg vitamin C, 
given in daily intraperitoneal doses. 
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Materials and methods 
Animals 
Male guinea pigs of a Hartley-derived strain, 
having a mean starting weight of 325 g + 47 g (s.d.), 
were obtained from a commercial supplier. These ani-
mals were obtained as young adults (5-6 weeks), ear-
tagged on receipt, and distributed into experimental 
groups by weight stratification to ensure comparable 
weights within each group. The animals were usually 
housed in small groups of 5 per cage. The animals were 
exposed to equal 12 hour periods of light and dark and 
pair-fed only a standard "dry" meal (Wayne
R Guinea 
Pig Diet) with no supplement. An ample supply of fresh 
water was made available to all groups. 
Materials 
All inorganic chemicals used in this study were of 
analytical grade. The following specialized organic 
reagents were used: sodium ascorbate (USP, Bronson), 
ascorbic acid (Mitheson, Coleman and Bell), bovine 
serum albumin (Miles Laboratories), alfa'alfa'dipyridyl 
(Aldrich Chemical Co.), heparin (Invenex). Freund's 
adjuvans for immunization was obtained from Sigma. 
Immunization 
All animals were kept on an ascorbate-free diet 
for 28 days. The animals were immunized with bovine 
serum albumin (BSA, Miles) 0.2 mg being admini-
stered in complete Freund's adjuvant on day O (0.025 
mg/foot pad and 0.1 mg in the nuchal skin) and again on 
day 14 (in 1% saline) intracutaneoulsy and sub-
cutaneously into the nuchal skin. Two studies were 
made, each involving 15 animals. Group A received 0, 
10 or 100 mg/day ascorbate while group B received 0, 
25 or 250 mg/day ascorbate. 
Within each group, animals were separated into 
three categories of five animals each and put on a daily 
schedule of intraperitoneal injections of 0, 10, 25, 100, 
or 250 mg Na-ascorbate (Bronson). Taking into 
account that the sodium content of crystalline Na-
ascorbate is 11,8% these were prepared in 2 ml 
aliquots of varying NaCl solution such that the daily 
sodium load was 29.5 mg/animal. 
Plasma and tissue analysis 
Blood was taken by cardiac puncture from each 
animal on experimental days 0, 14, and 28, into a 
syringe containing 200 units of Na-heparin (Invenex) in 
0.2 ml. At the end of the experiment all animals were 
anesthetized with sodium pentobarbital, and tissue 
samples were taken for evaluation of vitamin C. In all 
cases blood sample (day 14 and 28) and tissue samples 
(day 28) were removed from animals 20 hr after the 
ascorbate injection made on the previous day. 
L-ascorbic acid in the plasma and tissues of 
experimental animals was estimated by a micromethod 
described by Zannoni et al. (10). Blood was taken by 
cardiac puncture from each animal on experimental 
days 0, 14 and 28, into a syringe containing 200 units of 
Na-heparin (Ivenex) in 0.2 ml. Proteins are precipitated 
by adding 0.24 ml of 40% trichloracetatic acid to 2.0 
ml of plasma on ice. The samples are centrifuged at 
10.000 x g for 15 min. at 4"C and the following reagents 
then added to 1.0 ml of supernatant: 0.05 ml of 85% 
orthophosphoric acid, 0.05 ml of 8% alfa'alfa'dipyridyl 
in 95% ethanol, and 0.05 ml of 3% aqueous ferric 
chloride. The ferrous-dipyridyl chromophore is allo-
wed to develop for 20 minutes at room temperature and 
then read to 525 nm. Standards for each set of 
experimental samples are determined in duplicate. 
At the end of the experiment all animals were 
anesthetized with sodium pentobarbital, and tissue 
samples were taken for evaluation of vitamin C. In all 
cases blood samples (day 0, 14 and 28) and tissue 
samples (28 day) were removed from animals 20 hr 
after the ascorbate injection made on the previous day. 
Results 
In this experiment we present the results of two 
studies made 4 months aparat of different groups of 
animals receiving the equivalent of 0, 10, 25, 100, or 
250 mg ascorbic acid per day. In bouth experiments, 
immunized animals receiving no supplementation 
showed a reduction in ascorbic acid concentration of 55 
to 60% at 14 days and 67% to 74% at 28 days. The 
decreases in the maintenance level were 25% and 39% 
for the two periods, there being no difference between 
the 10% and 25 mg doses in relative change (table 1). 
Table 1. Effect of Na-ascorbate on plasma ascorbate levels in immunized male guinea pigs maintained 
on an ascorbate free diet 
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Guinea pigs receiving the megadoses, 100 mg 
and 250 mg/day, exhibited increased plasma levels, the 
former showing a greater increase than the latter (73% 
occuring at 14 days). At the end of experiment the gain 
in the 100 mg group had dropped to 12%, but in the 250 
mg group it continued to rise, reaching a concentration 
of 5.6 micro g/ul, or an increase of 60% above control. 
The eventual accommodation of the plasma level to 
high doses of ascorbate is confirmed by the results of 
the terminal plasma levels obtained on a separate group 
of animals (table 2). The values for the maintenance 
and megadose categories are identical. 
Of greater significance than the plasma levels are 
the ascorbate concentration measured in various tissues 
of selected animals than had been maintained for 28 
days on these ascorbate regimens. The greatest absolute 
and relative reductions in tissue ascorbate in animals 
completely deprived of vitamin C, occurred in the case 
of the pituitary, adrenal and spleen: 74 to 3.5; 68 to 1.0; 
and 32 to 0.3 mg ascorbate per 100 g in the respective 
cases. Under the same circumstances the ascorbate con-
centrations in the brain (cerebrum or hypothalamus) 
and in the eye dropped only to 20% of the control value. 
At a 10-fold increase of the maintenance dose, to the 
250 mg, there was no further increment in the tissue 
ascorbate levels except in the case of the pituitary and 
adrenal, but these were below the acceptable level of 
statistical significance. 
Discussion 
Hartley strain male guinea pigs with a mean 
weight of 325 g maintained ad libitum on a complete 
Reid-Briggs diet without vitamin C, but supplemented 
intraperitoneally with 10,25, 100 and 250 mg ascorbate 
per day, for a period of 28 days. 
It is known that the concentration of ascorbate in 
leucocytes is one of the highest known and is 
considered to be second only to that in the adrenals. The 
leucocytes are actively engaged in transporting large 
quantities of ascorbate to demaged tissues to an extern 
greater than that possible using blood or lymph in the 
absence of leucocytes because of the threshold limit of 
c. 1.4 to 2.4 mg ascorbate per 100 ml plasma enforced 
by the kidney (6). 
Polymorphonucler leucocytes and mast cells 
(11) of various mammalian species contain high con-
centrations of ascorbate. During the course of viral 
infections there is a rapid depletion of cellular ascorbate 
(4), the level returning on normal after recovery. The 
active accumulation of ascorbate by leucocytes incre-
ases in phase with chemotaxis of polymorphonucler 
leucocytes to infected areas (11) and reduced in re-
sponse to external agents such as steroids (12) which, 
according to various authors (13), act to suppress the 
hexose monophosphate shunt, eventually, depleting the 
polymorphonucler leucocytes of ascorbate. 
Several body tissues contain higher conce-
ntrations of ascorbic acid than plasma. Such a situation 
must involve active transport. The experimentally de-
termined values for a given tissue can vary significantly 
with the individual's age, with different individuals of 
the same age and with investigation - since strict co-
mparisons of individuals are not possible in post-
mortems with different time intervals between death 
and the post-mortem - and with different procedures 
adopted by different investigators (14, 15, 16, 17). 
In our experiment, imunized guinea pigs receiv-
ing no supplementation showed a reduction in ascorbic 
acid concentration of 59% at 14 days to 67% at 28 days. 
In the meantime, no difference between the 10 and 25 
mg doses in relative change. However, guinea pigs re-
ceiving the megadoses (100 mg and 250 mg/day) ex-
hibited increased plasma levels, the former showing a 
greater increase than latter. At the end of the experi-
ment the gain in the 100 mg group had dropped to 12%, 
but in the 250 mg group it continued to rise. 
Of greater significance than the plasma levels are 
the ascorbate concentrations measured in varios tissues 
of selected animals that had been maintained for 28 
days on these ascorbate regimens. Intraperitoneal admi-
nistration of Na-ascorbate a rapid increase of ascorbic 
acid plasma concentration. The greatest the ascorbate 
concentrations was obtained in the case of the adrenal 
(95,3), pituitary (89,1) and spleen (29,7) per 100 g in 
the respective cases. Under the same circumstances the 
ascorbate concentrations in the brain and in the eye 
dropped only to 20% of the control value (18,19,20). 
Table 2. Effects of ascorbate supplementation on tissue ascorbate levels in immunized male guinea pigs 
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There appears to be some indication that the 
plasma concentrations can be permanently elevated by 
"excessive" amounts of vitamin C (21, 22, 23). How-
ever, if there exist secondary reservoirs, such as the tis-
sue receptors,the plasma concentration is not so 
significant a parametar as is tissue storage (21, 14). In 
this connection we see that the ascorbate levels in et last 
two key metabolic tissues, the adrenal and pituitary, can 
be greatly increased by excessive amounts of vitamin C. 
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UTICAJ VITAMINA C NA KONCENTRACIJU ASKORBATA 
U PLAZMI I TKIVIMA 
Voja Pavlović i Zoran Pavlović 
Kod mladih, muških Hartley zamoraca, telesne težine 300-400 g, koji su bili na skor-
butičnoj dijeti (standard "dry" meal Wagne
1' Guinea pig diet), proučavanje uticaj razlicitih doza 
askorbinske kiseline na nivo vitamina C u plazmi i pojedinim tkivima. Životinje su bile imuni-
zovane sa bovin serum albuminom (BSA Miles), 0,2 mg sa kompletnim adjuvansom dato je na 
početku (0,025 mg/stopalo i 0,1 mg u predeo ušne školjke) eksperimenta i ista doza data je 
ponovo 14. dana (u 1% NaCl) ogleda u predeo ušne školjke. Životinje su bile podeljene u 5 
grupa, od po 5 životinja u svakoj grupi, i primile su, intraperitonealnom inokulacijom, po 0, 1, 
25, 100 i 250 mg Na-askorbata (Bronson). Krv je uzimana kardijalnom punkcijom od svake živ-
otinje na početku, 14. i 28. dana eksperimenta. Na kraju eksperimenta sve zivotinje su bile anes-
tezirane, a uzorci tkiva su uzimani neposredno posle žrtvovanja i odredivan je nivo vitamina C 
po metodi Zannoni i sar. Imunizovane životinje koje nisu dodatno dobijale vitamin C pokazuju 
redukciju koncentracije askorbata od 59% 14. dana i 67% 28. dana. Međutim, nema razlike u 
primeni doza od 10 i 25 mg. Zamorci koji su primili mega doze (100 i 250mg/nadan) pokazuju 
porast nivoa askorbata u plazmi. Na kraju eksperimenta, grupa koja je primila 100 mg imalaje 
pad od 12%, a u grupi koja je primala 250 mg vitamina C je kontinuirano rastao. 
Intraperitonealna aplikacija Na-askorbata, rapidno povećava koncentraciju askorbinske 
kiseline u plazmi i u tkivima. Najveća koncentracija askorbata zabelezena je u tkivu nadbubrega 
(95,3), hipofize (89,1) i u slezine (29,7), na lOOg ispitivanoga tkiva. Podistim uslovima koncen-
tracija askorbata u mozgu i u očnom sočivu je pala do 20% odkontrolnih vrednosti. Acta Medica 
Medianae 2003; 42(4):23-27. 
Ključne reči: vitamin C, plazma, tkiva 
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